New RAF kinase inhibitors in cancer therapy

Author： Martin-Liberal Juan Larkin James

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.9, 2014-06, pp. : 1235-1245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I/II RAF kinase inhibitors in cancer therapy

By Turajlic Samra Ali Zohra Yousaf Nadia Larkin James

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 739-749

Informa Healthcare

Access to resources Recommend Favorite

Raf kinase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1749-1750

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 84-125

Bentham Science Publishers

Access to resources Recommend Favorite

Kinase Inhibitors in Cancer Therapy: A Look Ahead

By Sedlacek H.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 435-476

Adis International

Access to resources Recommend Favorite

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite